Cargando…
What’s new in molecular genetic pathology 2021: solid tumors and NGS panel selection
The linchpin of precision medicine is molecular genetic and genomic testing. Molecular biomarkers are important for establishing precise diagnoses and for predicting therapeutic responses that enable cancer patients to receive personalized and targeted treatment. Below are highlights of the current...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601954/ https://www.ncbi.nlm.nih.gov/pubmed/34788978 http://dx.doi.org/10.4132/jptm.2021.09.01 |